- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Split Brain.
Displaying page 1 of 1.
EudraCT Number: 2015-003200-23 | Sponsor Protocol Number: 2013DR3084 | Start Date*: 2016-04-21 |
Sponsor Name:University Hospital Basel; Neurology | ||
Full Title: Biomarkers and antithrombotic treatment in cervical artery dissection (TREAT-CAD) | ||
Medical condition: cervical artery dissection | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-006270-15 | Sponsor Protocol Number: CAFQ056A2206 | Start Date*: 2009-03-02 |
Sponsor Name:Novartis Pharma AG | ||
Full Title: A multi-centre, randomized, double-blind, placebo-controlled, parallel-group, multiple oral dose study to assess the efficacy and tolerability of AFQ056 in reducing L-dopa induced dyskinesias in Pa... | ||
Medical condition: L-dopa induced dyskinesias in Parkinson’s patients with severe motor complications | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-022307-22 | Sponsor Protocol Number: BergenPsychosisProject2 | Start Date*: 2011-04-14 | |||||||||||
Sponsor Name:Haukeland University Hospital, Division of Psychiatry | |||||||||||||
Full Title: The Bergen Psychosis Project 2 | |||||||||||||
Medical condition: Patients with schizophrenia and related non-affective psychotic disorders, corresponding to ICD-10 diagnoses F10.5-19.5, and F20-29. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000063-79 | Sponsor Protocol Number: MN42989 | Start Date*: 2021-10-22 | ||||||||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | ||||||||||||||||||
Full Title: A PHASE IV MULTICENTER, OPEN-LABEL STUDY EVALUATING B CELL LEVELS IN INFANTS OF LACTATING WOMEN WITH CIS OR MS RECEIVING OCRELIZUMAB – THE SOPRANINO STUDY | ||||||||||||||||||
Medical condition: Multiple Sclerosis (MS) or Clinically Isolated Syndrome (CIS) [in line with the locally approved indications] | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) DE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.